Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Change in Cash (2021 - 2025)

P3 Health Partners (PIII) has disclosed Change in Cash for 5 consecutive years, with -$865000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Cash rose 91.44% year-over-year to -$865000.0, compared with a TTM value of -$29.6 million through Sep 2025, down 273.51%, and an annual FY2024 reading of $3.2 million, down 85.91% over the prior year.
  • Change in Cash was -$865000.0 for Q3 2025 at P3 Health Partners, up from -$2.0 million in the prior quarter.
  • Across five years, Change in Cash topped out at $45.9 million in Q2 2024 and bottomed at -$46.8 million in Q2 2022.
  • Average Change in Cash over 5 years is -$10.6 million, with a median of -$10.1 million recorded in 2023.
  • The sharpest move saw Change in Cash crashed 393.57% in 2022, then soared 91.44% in 2025.
  • Year by year, Change in Cash stood at $672083.0 in 2021, then crashed by 2615.17% to -$16.9 million in 2022, then surged by 40.35% to -$10.1 million in 2023, then crashed by 137.96% to -$24.0 million in 2024, then skyrocketed by 96.4% to -$865000.0 in 2025.
  • Business Quant data shows Change in Cash for PIII at -$865000.0 in Q3 2025, -$2.0 million in Q2 2025, and -$2.8 million in Q1 2025.